Termination Agreements in the Biotechnology Industry

206 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
AMENDMENT NUMBER ONE TO TERMINATION AGREEMENT AND TO MANUFACTURING AND SUPPLY AGREEMENT
Termination Agreements
ARDELYX, INC.
Biotechnology
DE
2016
Mutual Termination of Collaboration and License Agreement dated September 30, 2024, by and between Seres Therapeutics, Inc. and Société des Produits Nestlé S.A
Termination Agreements
Seres Therapeutics, Inc.
Biotechnology
DE
2024
Mutual Termination of License Agreement dated September 30, 2024, by and between Seres Therapeutics, Inc. and NHSc Rx License GmbH
Termination Agreements
Seres Therapeutics, Inc.
Biotechnology
DE
2024
Termination Notice dated October 28, 2024
Termination Agreements
Qrons Inc.
Biotechnology
2024
Assignment and Termination of Manufacturing Agreement, dated August 5, 2024, by and between Seres and Bacthera AG
Termination Agreements
Seres Therapeutics, Inc.
Biotechnology
NY
2024
Termination and Settlement Agreement, dated July 10, 2024, by and between the Company and Vifor (International) Ltd
Termination Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2024
Termination Agreement, dated July 22, 2024, by and between uniQure biopharma B.V. and Pierre Caloz
Termination Agreements
uniQure N.V.
Biotechnology
2024
Termination Agreement, dated July 1, 2024, by and between AlloVir, Inc. and BP Bay Colony LLC
Termination Agreements
Allovir, Inc.
Biotechnology
2024
Mutual Termination and Release Agreement, dated as of June 3, 2024, by and among LadRx Corporation, NantCell, Inc., ImmunityBio, Inc. and XOMA (US) LLC
Termination Agreements
CYTRX CORP
Biotechnology
2024
Termination of Consultancy Service Agreement between Hookipa Biotech GmbH and Malte Peters, effective March 31, 2024
Termination Agreements
HOOKIPA Pharma Inc.
Biotechnology
2024
Consent and Termination Agreement, dated February 22, 2024, by and between the Registrant and Royalty Pharma Investments 2019 ICAV
Termination Agreements
Blueprint Medicines Corp
Biotechnology
NY
2024
Termination Agreement dated as of March 16, 2024 between the Company and Pan-RAS Holdings, Inc
Termination Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Mutual Termination Agreement (Collaboration) by and between Checkpoint Therapeutics, Inc. and TG Therapeutics, Inc. dated September 30, 2023
Termination Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
2024
Mutual Termination Agreement (Sublicense) by and between Checkpoint Therapeutics, Inc. and TG Therapeutics, Inc. dated September 30, 2023
Termination Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
2024
Termination Agreement, dated December 20, 2023, by and among Janssen Pharmaceuticals, Inc., MeiraGTx UK II Limited and MeiraGTx Holdings plc
Termination Agreements
MeiraGTx Holdings plc
Biotechnology
2024
Termination of License Agreement, dated as of March 1, 2024, by and between Fresh Tracks Therapeutics, Inc. and Carna Biosciences, Inc
Termination Agreements
VICAL INC
Biotechnology
2024
Termination Agreement, dated February
Termination Agreements
Inhibrx, Inc.
Biotechnology
2024
Termination and Settlement Agreement, dated as of February 16, 2024, between the Company and Gavi Alliance
Termination Agreements
NOVAVAX INC
Biotechnology
2024
First Amendment to the Settlement and Termination Agreement, dated as of January 10, 2024, by and between the Registrant, BeiGene Switzerland GmbH, Bristol-Myers Squibb Company,...
Termination Agreements
BeiGene, Ltd.
Biotechnology
NY
2024
JVA Termination Agreement, by and among Biogen Therapeutics Inc., Samsung BioLogics Co., Ltd. and Samsung Bioepis Co., Ltd, dated April 20, 2020
Termination Agreements
Biogen Inc.
Biotechnology
2024
Termination Agreement, dated November 10, 2023, between Q32 Bio Inc. and Horizon Therapeutics DAC
Termination Agreements
Homology Medicines, Inc.
Biotechnology
2023
Mutual Termination and Release Agreement, dated September 17, 2023, by and between BeiGene Switzerland GmbH and Novartis Pharma AG
Termination Agreements
BeiGene, Ltd.
Biotechnology
CA
2023
Settlement and Termination Agreement, dated as of August 1, 2023, by and between the Registrant, BeiGene Switzerland GmbH, Bristol-Myers Squibb Company, Celgene Corporation,...
Termination Agreements
BeiGene, Ltd.
Biotechnology
NY
2023
Notice of Termination and Letter Agreement, dated September 18, 2023, by and between the Company and Joyce Reyes
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
2023
Notice of Termination and Letter Agreement, dated September 18, 2023, by and between the Company and Alfred P. Spada
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
2023
Notice of Termination and Letter Agreement, dated September 18, 2023 by and between the Company and Steven J. Mento
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
2023
Termination letter between H. Lee Moffitt Cancer Center and Research Institute, Inc. and the Company dated October 4, 2023 and effective as of September 30, 2023
Termination Agreements
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Biotechnology
2023
Termination Letter (Oxford License) September 22, 2023
Termination Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Mutual Termination and Release Agreement, dated September 21, 2023, between Sorrento Therapeutics, Inc. and Oramed Pharmaceuticals, Inc
Termination Agreements
Sorrento Therapeutics, Inc.
Biotechnology
TX
2023
Mutual Termination and Release Agreement, dated July 10, 2023, by and between BeiGene Switzerland GmbH and Novartis Pharma AG
Termination Agreements
BeiGene, Ltd.
Biotechnology
CA
2023
Termination Letter from MEI Pharma, Inc. to Infinity Pharmaceuticals, Inc., dated July 23, 2023
Termination Agreements
MEI Pharma, Inc.
Biotechnology
2023
Termination Agreement, by and between MEI Pharma, Inc. and Kyowa Kirin Co., Ltd. (formerly known as Kyowa Hakko Kirin Co., Ltd.) dated as of July 14, 2023
Termination Agreements
MEI Pharma, Inc.
Biotechnology
NY
2023
Mutual Termination Agreement, effective as of April 30, 2023, by and between F. Hoffman La Roche Ltd, Hoffman-La Roche Inc. and the Registrant
Termination Agreements
Blueprint Medicines Corp
Biotechnology
2023
Termination and Transfer Agreement made and effective as of April 6, 2023 by and between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Termination Agreements
Adaptimmune Therapeutics PLC
Biotechnology
CA
2023
Termination and Settlement Agreement, dated December 22, 2022, by and between Keryx Biopharmaceuticals, Inc. and BioVectra Inc
Termination Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2023
Mutual Termination Agreement dated December 22, 2022, by and between Amicus Therapeutics, Inc. and the Trustees of the University of Pennsylvania
Termination Agreements
AMICUS THERAPEUTICS, INC.
Biotechnology
PA
2023
Termination Agreement, dated February 7, 2023, by and between Oncocyte Corporation and Life Technologies Corporation
Termination Agreements
OncoCyte Corp
Biotechnology
CA
2023
Mutual Termination Agreement, dated December 12, 2022, by and between Exicure, Inc. and Ipsen Biopharm Limited
Termination Agreements
EXICURE, INC.
Biotechnology
2022
Termination of License Agreement, dated September 9, 2022, between Cue Biopharma, Inc. and MIL 21E, LLC
Termination Agreements
Cue Biopharma, Inc.
Biotechnology
2022
Termination Agreement and Release dated September 19, 2022 by and between iBio, Inc. and RubrYc Therapeutics, Inc
Termination Agreements
iBio, Inc.
Biotechnology
DE
2022
Termination, Amendment and Program Transfer Agreement dated August 2, 2022, by and between Atara Biotherapeutics, Inc., and Bayer AG
Termination Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2022